以下文章来源于风声OPINION ，作者刘正 风声OPINION . 理解复杂世界。 来源丨风声（ ID：ifengopinion ） 作者丨刘正 编辑丨 Berlin 图源丨Midjourney 和全世界的医保体系一样，中国也逃不开"质量-费用-可及性"的不可能三角：优质且费用低廉的医疗 服务，必然要用有限的医疗资源去满足无限的医疗需求，结果就是漫长的排队和严苛的分诊制。 近日，国家药监局公告注销80个药品注册证书，其中超55%为外资或合资公司产品。"多款进口药退 出中国"再次成为公众热议的话题。 根据媒体报道，此次名单涉及多个知名药物，如费卡华瑞的氯雷他定片、葛兰素史克的"万托林"、西 安杨森的"太宁栓"，以及部分集采品种、罕见病用药和GLP-1类药物。基于国家药监局公布的具体目 录看，这80个药品的注销情形均为"依申请注销"。也就是说，它们均由企业主动申请注销，更可能是 一种商业选择行为，而非被吊销或是存在危害人体健康等状况。 然而，进口药、原研药退出中国背后的是非曲直，却远比我们想象的更复杂。 同款原研药和仿制药 分子结构一模一样 就西药（化药）而言，无论是原研药还是仿制药，毋庸置疑，它们的有效成分都 ...

此前，张雪峰曾 因"新闻无用论""文科都是服务业" 等言论多次引发行业争论。 卢浮宫抢劫案两名嫌疑人已被捕 不满加拿大反关税广告，特朗普宣布对加方征收10%额外关税 *ST荣控：独立董事刘长坤无法取得联系 摩根大通将允许机构客户使用比特币和以太坊作为抵押品 茅台换帅：贵州省能源局局长陈华接任茅台集团董事长 虑。张雪峰还曾称"文科都是服务业"也冲上热搜，引发争议。（中国新闻周刊、封面新闻） 整理 ｜迟雨 点击上方【36氪随声听】，一键收听大公司热门新闻。听完音频记得添加进入 【我的小程序】 中哟！ 张雪峰解禁复播后称，文科大有可为 10月22日晚上，张雪峰全平台解禁，在抖音账号"张雪峰讲升学规划"恢复了直播，超4万人在线。他风格大变，称文科专业"大 有可为"。此前报道，9月24日，知名高考志愿导师张雪峰的微博、抖音、快手、B站及小红书平台的社交账号出现异常，被禁 止关注。这五个平台账号的粉丝合计超过6500万。 近年来张雪峰的言论多次引发讨论。2023年，张雪峰在直播中被问及"孩子想报考新闻专业"时表示，新闻专业就业面窄、收入 较低，"新闻无用论"引发巨大争议。张雪峰也曾表示"普通本科毕业生在就业市场上竞争力弱 ...

Core Points - The National Medical Products Administration (NMPA) announced the cancellation of registration certificates for 80 drugs, including well-known imported medications such as Fexofenadine tablets and Salbutamol inhalation solution [2][5] - Over 55% of the canceled drugs are from foreign pharmaceutical companies or joint ventures, while the remainder are from domestic companies [5] - The cancellations cover multiple therapeutic areas, including allergy treatment, respiratory diseases, diabetes, and oncology [5] - All cancellations were initiated by the companies themselves, indicating a commercial decision rather than safety concerns [5] Drug Specifics - Fexofenadine tablets (10mg) are used for allergic rhinitis and are classified as a Class A over-the-counter and Class A medical insurance drug, also part of the fourth batch of national centralized procurement [5] - GlaxoSmithKline's Salbutamol, an important emergency medication for asthma and COPD patients, is also part of the fourth batch of centralized procurement [5] - Other notable drugs in the cancellation list include Pfizer's Doxorubicin injection, Janssen's Tainin suppository, and Sanofi's GLP-1 diabetes drug Liraglutide injection [5] - Boehringer Ingelheim has preemptively canceled the approval for Dapagliflozin tablets, which were set to be included in the upcoming eleventh batch of centralized procurement, thus forfeiting its qualification for the next round of procurement [5] Market Impact - The withdrawal of these imported drugs is expected to have a limited impact on patient medication options, as there are many high-quality generic alternatives available in the domestic market that have passed consistency evaluations [5]